Clinical Trials Directory

Trials / Terminated

TerminatedNCT00157794

EnTRINSIC - EnPulse Trial on Search AV+ Influence

EnPulse Trial on Search AV+ Influence

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
135 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Right ventricular apical pacing in patients treated with a pacemaker is unnecessary in cases where patients have stable atrioventricular (AV)-conduction. Recent findings demonstrate that pacing even might have unfavourable effects, especially if patients suffer from additional cardiac diseases such as heart failure. The Search AV+ algorithm was designed to avoid ventricular pacing and support intrinsic AV-conduction in order to avoid possible detrimental effects of right ventricular apical pacing. The goal of the EnTRINSIC study is to assess the amount of ventricular stimulation, the amount of hospitalizations, the occurrence of atrial fibrillation and the usage of drugs in patients treated with pacemakers with an activated Search AV+ algorithm versus patients treated with an individual optimization of the pacemaker settings to minimize the amount of right ventricular pacing.

Conditions

Interventions

TypeNameDescription
DEVICESearch AV+ algorithm

Timeline

Start date
2004-02-01
Primary completion
2007-11-01
Completion
2007-11-01
First posted
2005-09-12
Last updated
2025-07-03

Locations

14 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00157794. Inclusion in this directory is not an endorsement.

EnTRINSIC - EnPulse Trial on Search AV+ Influence (NCT00157794) · Clinical Trials Directory